ArticleFrontiers in immunology2025

Reduced-dose obinutuzumab induces remission in refractory ANCA-associated vasculitis: a report of 16 cases.

Wenyi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.